Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
330.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.20 (0.364%)
Market Cap: £1.75b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Interim 2020 Dividend/Enhanced Script Correction

16 Dec 2020 12:00

RNS Number : 8736I
Hammerson PLC
16 December 2020
 

Hammerson plc (the 'Company')

16 December 2020

 

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative - Correction

 

The following amendment has been made to the Interim 2020 Dividend and Enhanced Scrip Dividend Alternative announcement released on 8 December 2020 at 13:15 under RNS No 9480H.

 

Therefore, 225,830,124 New Shares will be admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange, rather than 189,816,827 New Shares admitted to trading on the London Stock Exchange and 36,013,297 New Shares admitted to trading on the Johannesburg Stock Exchange, as stated in the main body of the announcement.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Hammerson plc

 

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative

 

16 December 2020

 

Further to the announcement of the Interim 2020 Dividend and the Enhanced Scrip Dividend Alternative on 11 November 2020, the Board of Hammerson plc (the Company) announced that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,108,216,704 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 225,830,124.

 

Therefore, 225,830,124 New Shares will be admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange, bringing the total number of issued 5 pence ordinary shares in the Company to 4,057,298,174.

 

The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange and the Johannesburg Stock Exchange on 18 December 2020. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchange. Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated 11 November 2020 in connection with the proposed Interim 2020 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/shareholderinformation/general-meeting.

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

Enquiries

Josh Warren, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVKKABBDBDDPBD
Date   Source Headline
5th Jun 20268:00 amRNSPublication of Final Terms
2nd Jun 20267:00 amRNSSuccessful pricing of 5-year EUR350m bond
29th May 20263:45 pmRNSHolding(s) in Company
26th May 202610:00 amRNSResults of Dividend Reinvestment Plan
22nd May 20264:15 pmRNSDirector/PDMR Shareholding
19th May 20262:00 pmRNSDirector/PDMR Shareholding
15th May 202612:30 pmRNSDirector/PDMR Shareholding
14th May 20263:00 pmRNSDirector/PDMR Shareholding
30th Apr 20264:30 pmRNSTotal Voting Rights
30th Apr 202611:15 amRNSResult of AGM
30th Apr 20267:00 amRNSHammerson CFO to retire
29th Apr 20267:00 amRNSHolding(s) in Company
28th Apr 20263:00 pmRNSDirector/PDMR Shareholding
24th Apr 20261:30 pmRNSEMTN Programme: Publication of Base Prospectus
24th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSHolding(s) in Company
8th Apr 20264:00 pmRNSDirector/PDMR Shareholding
7th Apr 202612:45 pmRNSTotal Voting Rights and Capital
30th Mar 202610:00 amRNSDirector/PDMR Shareholding
26th Mar 202611:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Mar 20262:00 pmRNSDirector/PDMR Shareholding
17th Mar 202610:00 amRNSDirector/PDMR Shareholding
17th Mar 20269:00 amRNSDividend Currency Conversion Announcement
25th Feb 20267:01 amRNSDividend Declaration
25th Feb 20267:00 amRNSFinal Results
6th Feb 20267:00 amRNSDirectorate change
28th Jan 20269:00 amRNSNotice of Results
20th Jan 20263:30 pmRNSHolding(s) in Company
22nd Dec 202511:30 amRNSDirector/PDMR Shareholding
22nd Dec 20259:30 amRNSDirector/PDMR Shareholding
15th Dec 20253:00 pmRNSDirector/PDMR Shareholding
11th Dec 20252:15 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSDirectorate change
21st Nov 20257:00 amRNSAcquisition of The Oracle and Trading Update
13th Nov 20251:45 pmRNSDirector/PDMR Shareholding
31st Oct 20257:45 amRNSResults of Dividend Reinvestment Plan
28th Oct 20251:00 pmRNSDirector/PDMR Shareholding
24th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 202511:00 amRNSDirector/PDMR Shareholding
22nd Oct 20254:30 pmRNSDirector/PDMR Shareholding
21st Oct 202512:00 pmRNSDirector/PDMR Shareholding
16th Oct 20251:00 pmRNSPublication of Final Terms
9th Oct 20257:00 amRNSBond Pricing, Guidance & Operational Update
25th Sep 20254:30 pmRNSHolding(s) in Company
19th Sep 20253:30 pmRNSDirector/PDMR Shareholding
11th Sep 20254:45 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNSAppointment of Rob Wilkinson as CEO
4th Sep 20253:30 pmRNSPublication of Supplementary EMTN Prospectus
29th Aug 202512:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.